Impact on Life Sciences & Healthcare Sector

We are covering COVID-19 related regulatory and other developments affecting life sciences & healthcare sector.

Estonia

See more news in Estonian

Latvia

Lithuania

See more news in Lithuanian

Belarus

  • Update on COVID-19 vaccine, its accessibility and the new pharmaceutical strategy for Europe

    Publication / Erika Žigutė, Lise-Lotte Lääne, Pirkko-Liis Harkmaa, Marina Golovnitskaya, Yauheni Budchanka, Ieva Andersone, Private: Gunvaldis Leitens

    In this newsflash, you will find our overview of the COVID-19 vaccine development, accessibility and legal aspects, as well as an update on the new pharmaceutical strategy for Europe and other relevant news. Our Life Sciences & Healthcare team is at your disposal should you need any advice on issues you are facing.   COVID-19 […]

  • Electronic prescriptions system gradually developing in Belarus

    Publication / Marina Golovnitskaya, Yauheni Budchanka

    Belarus in need of clear telemedicine regulations Currently there is no detailed regulation of telemedicine in Belarus. We are expecting an updated Law on Healthcare, which would address the situation. The key regulatory document providing main areas of the e-health system development is the “Concept of e-health development until 2022”, approved by Order of the […]

  • Belarus: COVID-specific news for Life Sciences & Healthcare sector

    Publication / Marina Golovnitskaya, Yauheni Budchanka

    Our Life Sciences & Healthcare team has prepared a summary of measures adopted up to April 14 2020 in Belarus specifically targeted at Life Sciences companies. The government has banned export of some medical goods until at least 1 June: respirators, chemical protection suits, bandages, cotton wool, gauze, medical gloves and masks, etc. The Ministry of […]

Contact us